Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

Dalton Transactions

Volumn 41, Issue 21, 2012, Pages 6507-6515

  Tanakit, Alisa ^a   Rouffet, Matthieu ^a   Martin, David P ^a   Cohen, Seth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COORDINATION CHEMISTRY; FIRST ROW TRANSITION METALS; INHIBITORY ACTIVITY; ION-SENSORS; MATRIX METALLOPROTEINASES; METALLOPROTEINASES; MMP INHIBITOR; SYNTHETIC PROCEDURES;

AMIDES; COORDINATION REACTIONS; ENZYME INHIBITION; MOLECULES; SULFUR COMPOUNDS; ZINC; ZINC COMPOUNDS;

CHELATION;

CHELATING AGENT; GELATINASE A; GELATINASE B; LIGAND; PROTEINASE INHIBITOR; SULFONAMIDE; ZINC;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; HUMAN; SYNTHESIS;

CHELATING AGENTS; HUMANS; LIGANDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEASE INHIBITORS; SULFONAMIDES; ZINC;

EID: 84862866633     PISSN: 14779226     EISSN: 14779234     Source Type: Journal    
DOI: 10.1039/c2dt12373h     Document Type: Article

References (28)

1. L. M. Coussens B. Fingleton L. M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 2002 295 2387 2392
2. J. Beckman et al., Human DNA polymerase I uses a combination of positive and negative selectivity to polymerize purine dNTPs with high fidelity Biochemistry 2006 46 2 448
3. M. Whittaker C. D. Floyd P. Brown A. J. H. Gearing Design and therapeutic application of matrix metalloproteinase inhibitors Chem. Rev. 1999 99 2735 2776
4. L. Bréhu A.-C. Fernandes O. Lavergne Regioselective preparation of 5-amino- and 6-amino-1,3-benzoxazole-4,7-diones from symmetrical diaminophenol and aminoresorcinol Tetrahedron Lett. 2005 46 9 1437
5. V. Elkin et al., Hydrogenation on palladium-containing granulated catalysts 3. Synthesis of aminobenzimidazoles by catalytic hydrogenation of dinitroanilines Russ. Chem. Bull. 2007 56 6 1216
6. M. L. Lindsey MMP induction and inhibition in myocardial infarction Heart Failure Rev. 2004 9 7 19
7. A. R. Katritzky R. P. Musgrave B. Rachwal C. Zaklika Synthesis of 4-hydroxy-1-methylbenzimidazole and 7-hydroxy-1-methylbenzimidazole Heterocycles 1995 41 2 345 352
8. E. Nuti T. Tuccinardi A. Rossello Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors Curr. Pharm. Des. 2007 13 2087
9. B. Pirard Insight into the structural determinants for selective inhibition of matrix metalloproteinases Drug Discovery Today 2007 12 640 646
10. B. G. Rao Recent developments in the design of specific matrix metalloproteinase inhibitors aided by structural and computational studies Curr. Pharm. Des. 2005 11 295 322
11. A. Yiotakis V. Dive Synthetic active site-directed inhibitors of metzincins: achievement and perspectives Mol. Aspects Med. 2008 29 5 329
12. F. E. Jacobsen J. A. Lewis S. M. Cohen The design of inhibitors for medicinally relevant metalloproteins ChemMedChem 2007 2 2 152 171
13. 2+ complexes J. Am. Chem. Soc. 2003 125 3889 3895
14. R. McRae P. Bagchi S. Sumalekshmy C. J. Fahrni In situ imaging of metals in cells and tissues Chem. Rev. 2009 109 10 4780 4827
15. M. M. Henary C. J. Fahrni Excited state intramolecular proton transfer and metal ion complexation of 2-(2′-hydroxyphenyl)benzazoles in aqueous solution J. Phys. Chem. A 2002 106 21 5210 5220
16. M. M. Henary et al., Excited-state intramolecular proton transfer in 2-(2′-arylsulfonamidophenyl)benzimidazole derivatives: the effect of donor and acceptor substituents J. Org. Chem. 2007 72 13 4784 4797
17. M. M. Henary Y. G. Wu C. J. Fahrni Zinc(ii)-selective ratiometric fluorescent sensors based on inhibition of excited-state intramolecular proton transfer Chem.-Eur. J. 2004 10 12 3015 3025
18. B. Macías et al., Synthesis and structural characterization of zinc complexes with sulfonamides containing 8-aminoquinoleine Z. Anorg. Allg. Chem. 2003 629 2 255 260
19. D. T. Puerta et al., Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity JBIC, J. Biol. Inorg. Chem. 2006 11 131 138
20. D. T. Puerta J. A. Lewis S. M. Cohen New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups J. Am. Chem. Soc. 2004 126 8388 8389
21. D. T. Puerta J. Mongan B. L. Tran J. A. McCammon S. M. Cohen Potent, selective pyrone-based inhibitors of stromelysin-1 J. Am. Chem. Soc. 2005 127 14148 14149
22. F. E. Jacobsen S. M. Cohen Using model complexes to augment and advance metalloproteinase inhibitor design Inorg. Chem. 2004 43 3038 3047
23. D. T. Puerta S. M. Cohen Elucidating drug-metalloprotein interactions with tris(pyrazolyl)borate model complexes Inorg. Chem. 2002 41 5075 5082
24. D. T. Puerta S. M. Cohen Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors Inorg. Chem. 2003 42 3423 3430
25. C. J. Fahrni T. V. O'Halloran Aqueous coordination chemistry of quinoline-based fluorescence probes for the biological chemistry of zinc J. Am. Chem. Soc. 1999 121 11448 11458
26. A. R. Katritzky R. A. Musgrave B. Rachwal C. Zaklika Synthesis of 4-hydroxy-1-methylbenzimidazole and 7-hydroxy-1-methylbenzimidazole Heterocycles 1995 41 2 345 352
27. D. Martin M. Rouffet S. M. Cohen Illuminating metal-ion sensors: benzimidazolesulfonamide metal complexes Inorg. Chem. 2010 49 22 10226 10228
28. C. J. Fahrni M. M. Henary D. G. VanDerveer Excited-state intramolecular proton transfer in 2-(2′-tosylaminophenyl)benzimidazole J. Phys. Chem. A 2002 106 34 7655 7663